Nebenwirkungen · Avonex
AVONEX 30 micrograms/0.5 ml solution for injection. · Abschnitt 4.8 · PDF-Seite 10
HOS-085758 · Präparat HOS-083191
The safety information obtained from the use of AVONEX as an active comparator in a 96 week open label, randomised trial in paediatric patients with relapsing remitting multiple sclerosis aged 10 to less than 18 years (with only 10% of the overall study population < 13 years) shows that in the AVONEX group (n=72), the following adverse events which are common in adult population were reported as very common in paediatric population: myalgia, pain in extremity, fatigue, and arthralgia.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-26T09:52:00Z · SHA-256 8664cc1a15fbdec79adb60465103f20a92b713f43676504055a5ffd792417483 · Passage 4373d1c172c7d1f5469ba0f2356699336ff806e1678870bbde03493436f90653 · Zeichen 8300–8789 im Abschnitt